Riik: Iisrael
keel: inglise
Allikas: Ministry of Health
LEVONORGESTREL
TRIMA ISRAEL PHARMACEUTICAL PRODUCTS MAABAROT LTD
G03AC03
TABLETS
LEVONORGESTREL 1.5 MG
PER OS
Not required
GEDEON RICHTER PLC, HUNGARY
LEVONORGESTREL
LEVONORGESTREL
Emergency contraseptive.
2021-05-31
K-00000-0.0 PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS’ REGULATIONS (PREPARATIONS) - 1986 A ‘MORNING AFTER PILL’ FOR PREVENTING PREGNANCY AFTER HAVING UNPROTECTED INTERCOURSE This medicine is to be dispensed without a doctor’s prescription POSTINOR ® Each pill contains: Levonorgestrel 1.5 mg. Inactive ingredients and allergens in the medicine: see section 2 under ‘Important information about some of the ingredients of the medicine’ and section 6 ‘Additional information’. THE MEDICINE IS MARKETED TO WOMEN AND GIRLS OVER 14 YEARS OF AGE WITHOUT A PRESCRIPTION. THE MEDICINE IS MARKETED ONLY WITH A PRESCRIPTION TO GIRLS UNDER 14 YEARS OF AGE. IF YOU HAVE STARTED TREATMENT WITHOUT ASKING A DOCTOR, SEE YOUR DOCTOR AS SOON AS POSSIBLE. Patient Safety Information Card: In addition to the patient information leaflet, Postinor has a patient safety information card. This card contains important safety information that you should be aware of and follow before and after taking Postinor. Read the patient safety information card and the patient information leaflet before using this medicine. Keep the card and leaflet so you can read them again if you need to. READ THE ENTIRE LEAFLET CAREFULLY BEFORE USING THIS MEDICINE. This leaflet contains concise information about this medicine. If you have further questions, refer to your doctor or pharmacist. You must take this medicine according to all the instructions in the section about dosage in this leaflet. Consult the pharmacist if you need more information. 1) WHAT IS THIS MEDICINE INTENDED FOR? Postinor is an emergency contraceptive for preventing pregnancy up to 72 hours (3 days) after having unplanned, unprotected intercourse, or after rape, or if there is reason to believe that the contraceptive you used is insufficient. THERAPEUTIC GROUP: Progestogens (female hormones). Postinor is an emergency contraceptive when taken up to 72 hours (3 days) after having unprotected intercourse, or if your usual contraceptive method has failed. Postinor contains a sy Lugege kogu dokumenti
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Postinor 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 1500 micrograms of levonorgestrel. Excipient with known effect: 142.5 mg lactose monohydrate. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet. Almost white, flat, rimmed tablet of about 8 mm diameter with an impressed mark of “G00” on one side. PATIENT SAFETY INFORMATION CARD The marketing of Postinor is subject to a risk management plan (RMP) including a 'Patient safety information card'. The 'Patient safety information card', emphasizes important safety information that the patient should be aware of before and during treatment. Please explain to the patient the need to review the card before starting treatment. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Emergency contraception. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION One tablet should be taken as soon as possible, preferably within 12 hours and no later than 72 hours after unprotected intercourse (see section 5.1). Women who have used enzyme-inducing drugs during the last 4 weeks and need emergency contraception are recommended to use a non-hormonal EC, i.e. Cu-IUD or take a double dose of levonorgestrel (i.e. 2 tablets taken together) for those women unable or unwilling to use Cu-IUD (see section 4.5). If vomiting occurs within three hours of taking the tablet another tablet should be taken immediately. Postinor can be used at any time during the menstrual cycle unless menstrual bleeding is overdue. After using emergency contraception it is recommended to use a local barrier method (e.g. condom, diaphragm, spermicide, cervical cap) until the next menstrual period starts. The use of Postinor does not contraindicate the continuation of regular hormonal contraception. _Paediatric population_ : There is no relevant use of Postinor for children of prepubertal age in the indication emergency contraception. Method of administration: For oral administration. 4.3 CONTRAINDICATIONS Hyper Lugege kogu dokumenti